Adicet Bio, Inc. (ACET) annual income statement — 18-year revenue, gross profit & net income history
Adicet Bio, Inc. (ACET) annual income statement — 18-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 | Jun'09 | Jun'08 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 24.99M | 9.73M | 17.9M | 995K | 8.18M | 558.52M | 546.95M | 510.18M | 499.69M | 499.69M | 444.39M | 412.43M | 346.63M | 322.65M | 359.59M |
| Revenue Growth % | - | - | - | -100% | 156.83% | -45.65% | 1699.3% | -87.84% | -98.54% | 2.12% | 7.21% | 2.1% | 0% | 12.44% | 7.75% | 18.98% | 7.43% | -10.27% | - |
| Cost of Goods Sold | 1.34M | 6.38M | 0 | 0 | 0 | 0 | 0 | 0 | 80K | 5K | 411.52M | 395.48M | 401.42M | 401.42M | 362.36M | 346.59M | 292.48M | 267.03M | 292.29M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | 0.98% | 0% | 75.24% | 77.52% | 80.33% | 80.33% | 81.54% | 84.04% | 84.38% | 82.76% | 81.28% |
| Gross Profit | -1.34M | -6.38M | 0 | 0 | 24.99M | 9.73M | 17.9M | 995K | 8.1M | 558.52M | 135.43M | 114.7M | 98.27M | 98.27M | 82.03M | 65.84M | 54.16M | 55.62M | 67.31M |
| Gross Margin % | - | - | - | - | 100% | 100% | 100% | 100% | 99.02% | 100% | 24.76% | 22.48% | 19.67% | 19.67% | 18.46% | 15.96% | 15.62% | 17.24% | 18.72% |
| Gross Profit Growth % | - | - | - | -100% | 156.83% | -45.65% | 1699.3% | -87.72% | -98.55% | 312.39% | 18.07% | 16.72% | 0% | 19.8% | 24.6% | 21.57% | -2.63% | -17.36% | - |
| Operating Expenses | 94.21M | 115.73M | 127.61M | 152.04M | 97.54M | 71.16M | 57.09M | 32.38M | 23.14M | 18.88M | 1K | 70.43M | 63.85M | 63.85M | 56.67M | 49.29M | 44.72M | 43.73M | 45.93M |
| OpEx % of Revenue | - | - | - | - | 390.32% | 731.38% | 318.91% | 3254.57% | 282.91% | 3.38% | 0% | 13.81% | 12.78% | 12.78% | 12.75% | 11.95% | 12.9% | 13.55% | 12.77% |
| Selling, General & Admin | 18.95M | 22.99M | 28.29M | 26.53M | 26.3M | 22.22M | 22.76M | 8.69M | 8.43M | 2.04M | 1K | 65.21M | 61.02M | 63.85M | 56.67M | 49.29M | 44.72M | 43.57M | 45.42M |
| SG&A % of Revenue | - | - | - | - | 105.22% | 228.37% | 127.13% | 873.57% | 103.02% | 0.36% | 0% | 12.78% | 12.21% | 12.78% | 12.75% | 11.95% | 12.9% | 13.51% | 12.63% |
| Research & Development | 76.6M | 99.13M | 99.32M | 106.04M | 71.25M | 48.94M | 34.33M | 23.69M | 14.72M | 16.84M | 5.94M | 5.22M | 2.83M | 0 | 0 | 0 | 0 | 153K | 506K |
| R&D % of Revenue | - | - | - | - | 285.1% | 503.01% | 191.78% | 2381.01% | 179.89% | 3.01% | 1.09% | 1.02% | 0.57% | - | - | - | - | 0.05% | 0.14% |
| Other Operating Expenses | -1000K | -6.38M | 0 | 19.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -95.55M | -122.11M | -127.61M | -152.04M | -72.55M | -61.43M | -39.19M | -31.39M | -14.96M | -18.88M | -1K | 44.27M | 34.42M | 34.42M | 25.37M | 16.55M | 9.44M | 11.89M | 21.38M |
| Operating Margin % | - | - | - | - | -290.32% | -631.38% | -218.91% | -3154.57% | -182.91% | -3.38% | -0% | 8.68% | 6.89% | 6.89% | 5.71% | 4.01% | 2.72% | 3.69% | 5.94% |
| Operating Income Growth % | - | 4.31% | 16.06% | -109.56% | -18.1% | -56.75% | -24.86% | -109.76% | 20.75% | - | -100% | 28.64% | 0% | 35.68% | 53.27% | 75.35% | -20.64% | -44.37% | - |
| EBITDA | -91.54M | -115.73M | -121.15M | -145.94M | -69.88M | -59.9M | -37.97M | -30.15M | -14.88M | -18.88M | 11.85M | 52.36M | 41.36M | 41.36M | 32.31M | 22.05M | 12.23M | 13.76M | 23.75M |
| EBITDA Margin % | - | - | - | - | -279.65% | -615.57% | -212.06% | -3030.15% | -181.93% | -3.38% | 2.17% | 10.26% | 8.28% | 8.28% | 7.27% | 5.35% | 3.53% | 4.26% | 6.61% |
| EBITDA Growth % | 20.01% | 4.47% | 16.99% | -108.83% | -16.68% | -57.76% | -25.92% | -102.57% | 21.15% | -259.33% | -77.37% | 26.6% | 0% | 28.02% | 46.51% | 80.25% | -11.08% | -42.08% | - |
| D&A (Non-Cash Add-back) | 4.01M | 6.38M | 6.47M | 6.1M | 2.67M | 1.54M | 1.23M | 1.24M | 80K | 5K | 11.85M | 8.09M | 6.94M | 6.94M | 6.94M | 5.5M | 2.8M | 1.87M | 2.38M |
| EBIT | -71.91M | -116.77M | -117.12M | -142.63M | -69.71M | -61.95M | -39.36M | -28.12M | -14.96M | -33.78M | -1K | 46.77M | 36.67M | 36.67M | 27.37M | 18.53M | 10.43M | 12.83M | 22.33M |
| Net Interest Income | 3.96M | 5.74M | 10.71M | 9.95M | 3.68M | -85K | 651K | 938K | 543K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 5.01M | 5.78M | 10.71M | 9.98M | 3.76M | 91K | 785K | 938K | 543K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 46K | 36K | 4K | 25K | 80K | 176K | 134K | 0 | 0 | 7M | 3.95M | 2.1M | 2.12M | 2.12M | 2.63M | 1.57M | 230K | 98K | 145K |
| Other Income/Expense | 4.7M | 5.31M | 10.49M | 9.38M | 2.76M | -691K | -302K | 3.27M | 5.08M | -14.9M | 0 | 402K | 134K | 134K | -626K | 412K | 765K | 839K | 812K |
| Pretax Income | -90.85M | -116.8M | -117.12M | -142.66M | -69.79M | -62.12M | -39.49M | -28.12M | -9.89M | -33.78M | -1K | 44.67M | 34.55M | 34.55M | 24.74M | 16.96M | 10.2M | 12.73M | 22.19M |
| Pretax Margin % | - | - | - | - | -279.27% | -638.48% | -220.59% | -2826.03% | -120.87% | -6.05% | -0% | 8.76% | 6.91% | 6.91% | 5.57% | 4.11% | 2.94% | 3.95% | 6.17% |
| Income Tax | 142K | 0 | 0 | 0 | 0 | -125K | -2.81M | 19K | -589K | 0 | 0 | 15.67M | 12.22M | 12.22M | 7.76M | 7.99M | 3.62M | 4.1M | 8.72M |
| Effective Tax Rate % | -0.16% | 0% | 0% | 0% | 0% | 0.2% | 7.13% | -0.07% | 5.96% | 0% | 0% | 35.09% | 35.37% | 35.37% | 31.36% | 47.13% | 35.5% | 32.23% | 39.28% |
| Net Income | -91M | -116.8M | -117.12M | -142.66M | -69.79M | -62M | -36.68M | -28.14M | -9.3M | -33.78M | -1K | 29M | 22.33M | 22.33M | 16.98M | 8.97M | 6.58M | 8.63M | 13.47M |
| Net Margin % | - | - | - | - | -279.27% | -637.19% | -204.87% | -2827.94% | -113.67% | -6.05% | -0% | 5.68% | 4.47% | 4.47% | 3.82% | 2.17% | 1.9% | 2.67% | 3.75% |
| Net Income Growth % | 20.88% | 0.27% | 17.9% | -104.41% | -12.57% | -69.04% | -30.35% | -202.59% | 72.47% | - | -100% | 29.88% | 0% | 31.49% | 89.35% | 36.27% | -23.73% | -35.95% | - |
| Net Income (Continuing) | -91M | -116.8M | -117.12M | -142.66M | -69.79M | -62M | -36.68M | -28.14M | -9.3M | -33.78M | -1K | 29M | 22.33M | 22.33M | 16.98M | 8.97M | 6.58M | 8.63M | 13.47M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -8.47 | -16.95 | -21.28 | -52.96 | -27.20 | -32.00 | -80.16 | -24.32 | -4.96 | -20.00 | -0.00 | 18.56 | 14.88 | 14.88 | 11.52 | 6.24 | 4.80 | 6.24 | 9.92 |
| EPS Growth % | 57.49% | 20.35% | 59.82% | -94.71% | 15% | 60.08% | -229.61% | -390.32% | 75.2% | - | -100% | 24.73% | 0% | 29.17% | 84.62% | 30% | -23.08% | -37.1% | - |
| EPS (Basic) | - | -16.95 | -21.28 | -52.96 | -27.20 | -32.00 | -80.16 | -24.32 | -4.96 | -20.16 | -0.00 | 18.88 | 15.04 | 15.04 | 11.68 | 6.40 | 4.80 | 6.40 | 10.08 |
| Diluted Shares Outstanding | 10.75M | 6.89M | 5.49M | 2.69M | 2.57M | 1.93M | 457.5K | 1.16M | 1.86M | 1.69M | 1.75M | 1.56M | 1.5M | 1.5M | 1.47M | 1.43M | 1.38M | 1.37M | 1.36M |
| Basic Shares Outstanding | 10.75M | 6.89M | 5.49M | 2.69M | 2.57M | 1.93M | 457.5K | 1.16M | 1.86M | 1.67M | 1.75M | 1.53M | 1.48M | 1.48M | 1.45M | 1.42M | 1.37M | 1.34M | 1.33M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quick answers to the most common questions about buying ACET stock.
For fiscal year 2025, Adicet Bio, Inc. (ACET) reported total revenue of $0.0M. This represents a 100.0% decline compared to $359.6M in 2008.
Adicet Bio, Inc. (ACET) reported a net loss of $116.8M for the fiscal year ending 2025.